SHARE-BASED COMPENSATION (Tables)

12 Months Ended

Oct. 31, 2016

Share-based Compensation [Abstract]

Allocated Share-based compensation expense disclosure

The impact on our results for share-based compensation was as follows:

	Years Ended October 31,
	2016		2015		2014
	(in millions)
Cost of products and services	$	14	$	11	$	13
Research and development	6		5		7
Selling, general and administrative	40		39		39
Share-based compensation expense in continuing operations	60		55		59
Share-based compensation expense in discontinued operations	—		—		39
Total share-based compensation expense	$	60	$	55	$	98

Share-based compensation arrangement by share-based payment award fair value assumptions and methodology schedule

The following assumptions were used to estimate the fair value of employee stock options and LTPP grants.

	Years Ended October 31,
	2016	2015	2014
Stock Option Plans:
Weighted average risk-free interest rate	—	1.75%	1.69%
Dividend yield	—	1%	1%
Weighted average volatility	—	28%	39%
Expected life	—	5.5 years	5.8 years
LTPP:
Volatility of Agilent shares	24%	25%	36%
Volatility of selected peer-company shares	14%-50%	12%-57%	13%-57%
Price-wise correlation with selected peers	35%	37%	47%

Summary of stock option award activity

The following table summarizes employee stock option award activity of our employees and directors for 2016.

	Options Outstanding		Weighted Average Exercise Price
	(in thousands)
Outstanding at October 31, 2015	5,712		$	31
Granted	—		$	—
Exercised	(1,547	)	$	25
Cancelled/Forfeited/Expired	(59	)	$	33
Outstanding at October 31, 2016	4,106		$	33

Forfeited and expired options from total cancellations in 2016 were as follows:

	Options Cancelled	Weighted Average Exercise Price
	(in thousands)
Forfeited	31	$	38
Expired	28	$	28
Total Options Cancelled during 2016	59	$	33

Schedule of share-based compensation, shares authorized under stock option plans, by exercise price range

The options outstanding and exercisable for equity share-based payment awards at October 31, 2016 were as follows:

	Options Outstanding						Options Exercisable
Range of Exercise Prices	Number Outstanding	Weighted Average Remaining Contractual Life	Weighted Average Exercise Price		Aggregate Intrinsic Value		Number Exercisable	Weighted Average Remaining Contractual Life	Weighted Average Exercise Price		Aggregate Intrinsic Value
	(in thousands)	(in years)			(in thousands)		(in thousands)	(in years)			(in thousands)
$0 - 25	361	2.4	$	18	$	9,268	361	2.4	$	18	$	9,268
$25.01 - 30	1,633	5.0	$	26	28,095		1,324	4.7	$	26	22,741
$30.01 - 40	898	7.1	$	39	3,995		439	7.1	$	39	1,957
$40.01 - over	1,214	8.0	$	41	3,259		302	8.0	$	41	815
	4,106	6.1	$	33	$	44,617	2,426	5.2	$	29	$	34,781

Schedule of intrinsic value of options exercised and the fair value of options granted

The following table summarizes the aggregate intrinsic value of options exercised and the fair value of options granted in 2016, 2015 and 2014:

	Aggregate Intrinsic Value		Weighted Average Exercise Price		Per Share Value Using Black-Scholes Model
	(in thousands)
Options exercised in fiscal 2014	$	98,075	$	30
Black-Scholes per share value of options granted during fiscal 2014					$	19
Options exercised in fiscal 2015	$	33,258	$	24
Black-Scholes per share value of options granted during fiscal 2015					$	11
Options exercised in fiscal 2016	$	26,913	$	25
Black-Scholes per share value of options granted during fiscal 2016					$	—

Non-vested award activity disclosure

The following table summarizes non-vested award activity in 2016 primarily for our LTPP and restricted stock unit awards.

	Shares		Weighted Average Grant Price
	(in thousands)
Non-vested at October 31, 2015	2,417		$	36
Granted	1,732		$	40
Vested	(607	)	$	35
Forfeited	(94	)	$	39
Change in LTPP shares in the year due to not meeting performance conditions	(386	)	$	28
Non-vested at October 31, 2016	3,062		$	40